Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy

Mehmet Cilingiroglu, Venkata Chilakapati, Stephanie Dunlap, Massoud A. Leesar

Research output: Contribution to journalArticlepeer-review


Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).

Original languageEnglish (US)
Pages (from-to)120-123
Number of pages4
JournalCardiovascular Revascularization Medicine
Issue number2
StatePublished - Apr 2010
Externally publishedYes


  • Cardiac allograft vasculopathy
  • Drug-eluting stent
  • Restenosis
  • Stent fracture

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy'. Together they form a unique fingerprint.

Cite this